Quantum X Labs Inc.

Name: Quantum X Labs Inc. standardized financial statements, quarterly
Creator: Listed

QXLNasdaqCIK 797542TechnologyFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$293.0k, Q2 FY2026

Operating income−$1.4m, Q2 FY2026

Net income$2.5m, Q2 FY2026

Quantum X Labs Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	15.7	15.9	10.0	7.3	6.3	3.3	2.7	2.3	2.7	not reported	not reported	0.3
Cost of revenue	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Gross profit	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Research and development	$m	0.7	0.7	0.7	0.5	0.3	(0.8)	0.0	0.0	0.1	(0.3)	not reported	0.2
Operating income	$m	(1.7)	(6.0)	(1.0)	(5.5)	(0.9)	6.6	(0.1)	(1.0)	(3.6)	7.3	(0.6)	(1.4)
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$m	(0.1)	(0.1)	0.0	(0.0)	(0.1)	0.2	0.0	(0.1)	(0.3)	0.5	(0.0)	(0.1)
Net income	$m	(1.5)	(5.3)	(1.0)	(7.2)	(0.6)	(3.3)	(3.7)	(11.7)	(3.4)	(0.6)	(0.6)	2.5
Diluted EPS	$ per share	(0.10)	not reported	0.27	1.91	0.12	not reported	0.68	(1.61)	0.32	not reported	0.05	0.12
Basic EPS	$ per share	(0.10)	not reported	0.27	1.91	0.12	not reported	0.68	(1.61)	0.32	not reported	0.05	0.17

Balance sheet

Cash and equivalents$2.4m, Q2 FY2026

Long-term debt$195.0k, Q2 FY2026

Shareholders' equity$25.8m, Q2 FY2026

Quantum X Labs Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	2.6	1.8	1.3	0.6	1.4	0.0	0.2	2.0	2.2	1.0	1.8	2.4
Current assets	$m	18.8	17.8	12.8	11.4	12.9	7.8	6.5	4.1	4.1	1.7	2.9	3.5
Total assets	$m	50.2	43.3	37.5	30.0	30.8	22.0	26.4	20.1	16.9	10.8	27.7	31.2
Current liabilities	$m	20.6	19.8	15.9	15.5	16.9	12.9	15.4	12.7	8.6	4.1	4.2	4.0
Total liabilities	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Long-term debt	$m	2.7	3.1	2.4	1.7	1.1	0.5	not reported	not reported	0.8	0.6	0.4	0.2
Current portion of debt	$m	1.9	1.4	2.1	2.1	2.5	3.1	2.9	2.2	0.8	0.8	0.8	0.8
Short-term borrowings	$m	6.0	5.0	4.4	2.4	2.6	1.5	2.9	3.2	1.3	0.3	0.3	0.3
Shareholders' equity	$m	20.1	14.8	13.8	7.1	9.0	5.8	7.3	4.5	5.6	5.0	21.6	25.8

Cash flow

Operating cash flow−$1.1m, Q2 FY2026

Capital expenditure$186.0k, Q2 FY2026

Quantum X Labs Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(276)	195	107	1,349	534	(447)	(409)	(427)	(1,715)	(218)	(604)	(1,062)
Capital expenditure	$k	3.0	3.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	186
Dividends paid	$k	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)20.07m, Q2 FY2026

Quantum X Labs Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	14.8	14.8	14.8	14.9	3.7	3.8	5.1	5.4	7.2	10.5	11.5	20.1

Shares outstanding: 21.57m at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. Listed shows no prices and gives no investment advice.